Cupid Limited · NSE:CUPID
Cupid — Q2 FY2023 Earnings Presentation
31 slides from Cupid's earnings presentation, Nov 14, 2022
Slide 1: Cupid Limited cover letter to exchanges
CUPD LIMITE,I) Manufacturers and Suppliers of Male & Female Condoms Date: - 14th November,2022 To, Department of Corporate Services, The National Stock Exchange of lndia Ltd. BSE LlMITED, Exchange Plaza, Sth Floor, Bandra-Kurla Phiroze Jeejeebhoy Towers, Complex, Bandra (East), Dalal Street, Mumbai
Slide 2: Investor Presentation Q2 FY23
Investor Presentation Q2 FY23
Slide 3: Safe Harbour
SAFE HARBOUR Except for the historical information contained herein, statements in this presentation and the subsequent discussions, which include words or phrases such as "will", "aim", "will likely result", "would", "believe", "may", "expect", "will continue", "anticipate", "estimate", "intend", "
Slide 4: Our Vision: We help the world play safe
OUR VISION We at Cupid Limited are committed to play a promising role for the fight against HIV/AIDS & Prevention of Unintended Pregnancy. Developing a safe and effective methodology against HIV is critical to our efforts to control the devastating pandemic of HIV/AIDS as WE HELP THE WORLD P L AY S
Slide 5: Cupid at a Glance
ADD product photos CUPID AT A GLANCE 4
Slide 6: Who Are We Today?
WHO ARE WE TODAY? India’s Leading manufacturer 1st company in of male condom, female 20+ years of Industry the world to get WHO/UNFPA Debt Free condoms and water based experience Prequalification for both Male balance Sheet lubricant jelly & Female Condom Annual Capacity: Employs 100+ people with Ma
Slide 7: Cupid's Journey
CUPID’S JOURNEY 2020-21 2018-20 2016 Further 2015 expanded Received 2012 capacity of male Cupid brand order in 2018 2010 launched in worth $17 mn condom to 480 Received order 2006-07 Mn. worth $16.3 India . and another Prequalification Started Medical 1998 mn for female Starts order worth $ Cupid’s
Slide 8: Financial Performance
ADD product photos FINANCIAL PERFORMANCE 7
Slide 9: Quarterly Highlights (Q2FY23)
QUARTERLY HIGHLIGHTS (Q2FY23) In ₹mn REVENUE EBITDA PAT 120.0 85.8 452.5 308.2 327.9 46.3 46.5 57.9 55.2 Q1FY23 Q2FY23 Q2FY22 Q1FY23 Q2FY23 Q2FY22 Q1FY23 Q2FY23 Q2FY22 Q2FY23 Performance • Total Operating income was ₹452.5 million (mn) for Q2FY23 as compared to ₹327.9 mn in the corresponding period
Slide 10: Business Highlights of Q2FY23
BUSINESS HIGHLIGHTS OF Q2FY23 SALES BREAKUP • Exports in Q2FY23 was 97% (88% in Q2FY22) of the total revenue while domestic sale was 3% (12% in Q2FY22). • The product mix in Q2FY23 was Male condoms (MC) 67% (78% in Q2FY22), Female condoms (FC) with 17% (13% in Q2FY22), Others (Lubricant Jelly) 15% (
Slide 11: Income Statement
INCOME STATEMENT Particulars (In ₹mn) Q2FY22 Q3FY22 Q4FY22 Q1FY23 Q2FY23 Income from Operations 327.9 362.2 313.6 308.2 452.5 Total Income 340.8 369.8 324.3 314.9 462.1 Cost of Material Consumed 164.0 148.9 188.3 161.9 201.7 Change in Inventory -11.2 46.0 -34.0 -14.5 -27.3 Employee Benefit Expenses
Slide 12: About Us
ADD product photos ABOUT US 11
Slide 13: Cupid Factory (Area >100000 sq. feet)
CUPID FACTORY (AREA >100000 SQ. FEET) 12
Slide 14: Technical Capability
TECHNICAL CAPABILITY • World Class manufacturing facility with conformity with global standards and best quality practices • Housed with Richter-Hi Tech German dipping technology and online electronic testing. So, every unit produced is electronically tested before dispatch • Established operating p
Slide 15: In-House Laboratory
IN-HOUSE LABORATORY W E L L E Q U I P P E D I N - H O U S E L A B O R AT O R Y W I T H T R A I N E D A N D E X P E R I E N C E D P E R S O N N E L TO CO N D U C T B E LO W TESTING • In - co m ing R a w & Pa ck a ging m a te ria l te st ing • In-process product testing • Finished product testing: o D
Slide 16: Certifications & Accreditations
CERTIFICATIONS & ACCREDITATIONS U N F PA - ISO 9001:2015 P R E Q UA L I F I C AT I O N ISO 13485:2016 SABS MARK USFDA (510K) FOR MALE ISO 14001:2015 CONDOMS CE 2460 BRA ZIL ANVISA 15
Slide 17: Products and Business
PRODUCTS AND BUSINESS • Extra Large Condoms Capacity MALE FEMALE • Made up of Latex • Specialty Condoms 52 Million CONDOMS CONDOMS • 100% Indian made and costs • Ultra-Thin Condoms Per Annum considerably lesser than the • Plain Condoms imported & packed foreign product. • Dotted Condoms Capacity • H
Slide 18: Male Condoms
MALE CONDOMS Male Condoms are available in different varieties like Plain, Dotted, Ribbed, Multi-textured, Extra Large & Ultra-Thin. They are also available in different flavours & colours with 49mm, 53mm & 56mm width. Primary packs are available in rectangular, square & circular format. All condoms
Slide 19: Female Condoms
FEMALE CONDOMS • Cupid Female Condom commercial production started in 2010. • Cupid Female Condoms are available with or without flavor and color. • Installed capacity of 52 million pieces per year. 18
Slide 20: Water Based Lubricants
WATER BASED LUBRICANTS • Water based Lubricant Jelly is used with condoms to enhance pleasure. Cupid Limited started manufacturing lubricant jelly in 2015. • Water based Lubricants are available in different pack sizes starting from 4.5ml sachets, Laminated Tubes and bottles. • Installed capacity of
Slide 21: Upcoming Products: In Vitro Diagnostic Device (IVD)
UPCOMING PRODUCTS:- IN VITRO DIAGNOSTIC DEVICE (IVD) Syphilis Ab Test HIV 1 & 2 Ab Test ▪ Chromatographic immunoassay ▪ Chromatographic immunoassay ▪ Detection of Specific TP antibodies ▪ Detection of HIV 1 & 2 antibodies ▪ Specimen: Serum /Plasma ▪ Specimen: Serum/plasma ▪ Result interpretation tim
Slide 22: Upcoming Products: In Vitro Diagnostic Device (IVD)
UPCOMING PRODUCTS:- IN VITRO DIAGNOSTIC DEVICE (IVD) Malaria Pf-PAN Ag Test Hepatitis B (HbsAG) Ag Test ▪ Chromatographic immunoassay ▪ Chromatographic immunoassay ▪ Detection of Pf-HRP II and PAN- ▪ Detection of Hepatitis B antigens pLDH specific antigens ▪ Specimen: Serum/Plasma ▪ Specimen: Whole
Slide 23: Upcoming Products: In Vitro Diagnostic Device (IVD)
UPCOMING PRODUCTS:- IN VITRO DIAGNOSTIC DEVICE (IVD) Pregnancy HCG Detection Test Dengue IgG-IgM Ab Test ▪ Chromatographic immunoassay ▪ Chromatographic immunoassay ▪ Detection of HCG levels ▪ Detects Dengue Antibodies ▪ Result interpretation time: 5 min ▪ Specimen: Serum/Plasma ▪ Specimen: Urine ▪
Slide 24: Strong In-House Manufacturing Capabilities
Strong In-House Manufacturing Capabilities SEALING SECTION TESTING SECTION DIPPING SECTION COMPOUNDING SECTION 23
Slide 25: Strong In-House Manufacturing Capabilities
Strong In-House Manufacturing Capabilities QUALITY TESTING L U B R I C A N T J E L LY LAB SECTION FEMALE CONDOM SECTION SECTION PA C K I N G S E C T I O N 24
Slide 26: Cupid's Geographical Presence
CUPID’S GEOGRAPHICAL PRESENCE 25
Slide 27: Commercial Performance
COMMERCIAL PERFORMANCE Turnover in Million. USD 25 21.86 20.36 20 18.06 15 10 5 0 2019-20 2020-21 2021-22 Turnover in Million. USD 26
Slide 28: Commercial Performance: Sales Data
COMMERCIAL PERFORMANCE 3 Years Sales Data 450 397.22 400 378.86 350 329.22 300 250 200 150 100 50 23.06 13.09 6.50 0 2019-20 2020-21 2021-22 Sale Quantity(Male condom) in Million Pieces Sale Quantity(Female Condom) in Million Pieces 27
Slide 29: Cupid in Social Media
CUPID IN SOCIAL MEDIA 28
Slide 30: Corporate Information
CORPORATE INFORMATION Stock Profile Listing BSE(1995) / NSE (2016) Promoters, Others, 45.06% Issued Shares (mn) 13.338 54.35% Share Price(INR)^ ~249 Market Cap^(INR mn) ~3,326 Institutions, 52-week Range(INR) 353.70-192.05 0.59% Contact Details Corporate Information Saurabh Karmase (Company Secretar
Slide 31: Thank You
Thank You 30